Blood vessel health in adults with Down syndrome
Looks at how well blood vessels work in adults with Down syndrome.
Key facts
- Who runs it
- University of Nevada, Las Vegas
- Where
- Las Vegas, United StatesSee the site
- Trial code
- Registry title
- Vascular Function in Adults With Down Syndrome
- Status
- Recruiting
- People taking part
- 46 people, planned
- Started
- 9 Apr 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Observational, 2 groups
- Record updated
- 2 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for generally healthy, inactive adults with Down syndrome and adults without Down syndrome of the same age and sex. It studies how well blood vessels work.
- Age
- 18 to 35 years
- Sex
- All sexes
- Disease stage
- People with Down syndrome must have a diagnosis of Down syndrome trisomy 21. Their thyroid function must be normal, or stable (with stable medicines) for at least 6 months. All people must be generally healthy and inactive: less than 30 minutes of moderate physical activity per day.
- Earlier treatment
- People cannot join if they take heart medicines that affect heart rate, blood pressure or artery function, blood thinners, or anti-inflammatory medicines such as NSAIDS.
Main reasons for not taking part
- Heart problem from birth that has not been fixed, or blood vessel disease, blood clots or clotting disorders
- Asthma or other lung disease
- Blood pressure above 140/90 mmHg or below 90/60 mmHg, or past fainting or near-fainting
- Diabetes (HbA1c >7.5% (58 mmol/mol) or using sugar-lowering medicine), or BMI >40
- Current smoking, pregnancy, plans to get pregnant, breastfeeding, or not willing to use birth control
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- between 18 and 35 years old
- generally healthy
- sedentary (defined as being involved in less than 30 minutes of moderately-intense physical activity per day); Additionally, for the participants with Down syndrome:
- diagnosis of Down syndrome trisomy 21
- normal thyroid function or stable thyroid function (and medications) for at least 6 months
Who cannot take part
- unresolved congenital heart disease
- atherosclerotic or other vascular disease (such as blood clot history or clotting disorders)
- asthma or other pulmonary disease
- hypertension (defined as BP >140/90 mmHg); blood pressure below 90/60 mmHg
- history of pre-syncope or syncope
- heart medications affecting heart rate, blood pressure, or arterial function, including blood thinners; anti-inflammatory medication, including Nonsteroidal anti-inflammatory drugs (NSAIDS)
- diabetes (defined as glycated hemoglobin (HbA1c) of >7.5% or use of glucose-lowering medication)
- severe obesity (defined as body mass index (BMI) >40)
- current smoking
- currently pregnant or planning to become pregnant during the study period
- currently breastfeeding
- unable or unwilling to use an acceptable method of contraception during the study timeframe
- positive pregnancy test at screening
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 35 years old?
Where in United States
- University of Nevada Las Vegas - UNLVLas Vegas, United StatesContact: Thessa Hilgenkamp, PhDTaking people
About the trial
What the trial wants to find out
Adults with Down syndrome (Ds) are often thought to have a lower risk of heart and blood vessel disease because they tend to have lower blood pressure (BP) and fewer heart attacks than people without Ds. However, recent research suggests that heart and blood vessel diseases, including stroke, are becoming a more common cause of death in adults with Ds as life expectancy increases. Despite these findings, studies examining heart and blood vessel health in adults with Ds have produced mixed results, making it difficult to determine their true risk and whether preventive strategies are needed. This study will investigate the health of blood vessels in adults with Ds and compare the results with those of adults without Ds. Healthy blood vessels are important because they help deliver blood and oxygen throughout the body. Changes in blood vessel function and stiffness can occur with aging and may increase the risk of heart disease, stroke, kidney disease, and memory problems. The study aims to determine whether adults with Ds experience changes in blood vessel health that may place them at increased cardiovascular risk. Specifically, the study will: (1) Examine how well blood vessels function in adults with Ds; (2) Measure the stiffness of arteries in adults with Ds; (3) Compare two methods used to assess blood vessel function to determine whether a simpler exercise-based test provides results similar to a commonly used standard test. The findings may improve understanding of cardiovascular risk in adults with Ds and help guide future strategies to promote healthy aging in this population.
The 2 groups in the trial
- Down Syndrome
Adults with Down Syndrome
- Control group
Age- and sex-matched adults without Down Syndrome
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Vascular Function in Adults With Down Syndrome
- Plain-language title
- Blood vessel health in adults with Down syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07630207, who can take part
- Record updated
- 2 October 2026